EUVIMEDEUVIMED entdecken
Open Access

Lamotrigine Restores Impairments in Theta Rhythms and LTP as Early Biomarkers of Aβ1-42-Induced Hippocampal Network Dysfunction

Maciej Studzian, Bartosz Bobula, M Bruce MacIver, Renata Bocian, Anna Kobrzycka, Bartosz Caban, Tomasz Kowalczyk, Jacek Grebowski, Sylwia Michlewska, Maciej M Jankowski, Krzysztof Tokarski, Paulina Kazmierska-Grebowska

aging and disease · 2025

DOI: 10.14336/ad.2025.0796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift aging and disease, 2025. Verfasst von Maciej Studzian und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Lodz, Faculty of Biology and Environmental Protection, Department of Oncobiology and Epigenetics, 90-236 Lodz, Poland. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Theta Rhythm, Peptide Fragments, Long-Term Potentiation. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuronal excitation/inhibition (E/I) imbalance, epileptiform activity, and synaptic dysfunction are present in individuals diagnosed with dementia, including sporadic Alzheimer's disease (sAD), even at early stages. These abnormalities are associated with altered neuronal oscillatory activity, as seen in EEG recordings of sAD patients and transgenic rodents. Hippocampal theta oscillations are crucial for sensorimotor integration, memory consolidation, and network coordination, and depend on synaptic and ionic mechanisms, including the Ih current, mediated by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Lamotrigine (LTG), an HCN channel modulator, influences neuronal excitability and oscillations. Amyloid beta (Aβ) peptide, specifically Aβ1-42 form plays a key role in AD pathology, promoting hyperexcitability, synaptic dysfunction, and neurodegeneration, particularly in the hippocampus (HPC) and associative cortices. However, only a few electrophysiological studies have examined HPC theta in relation to early cognitive deficits in sAD animal models. Our first goal was to study the temporal progression of theta oscillations impairment following repeated unilateral intracerebroventricular (ICV) Aβ1-42 infusions in rats at 7, 14, and 21 days, in vivo and in vitro. Second, we assessed whether local LTG administration could restore theta oscillations and long-term potentiation (LTP) in this model. We found that: i) Aβ1-42 ICV infusions led to significant reductions in theta amplitude and power on days 7 and 14, with a complete loss by day 21; ii) LTG restored LTP and theta rhythms in terms of power and amplitude in HPC obtained from Aβ1-42-treated animals 14 days post-ICV infusion; iii) histological analysis confirmed neurodegeneration, Tau hyperphosphorylation, astrogliosis, increased number of parvalbimun positive (PV+) interneurons, and GluN2B receptor upregulation in HPC of Aβ1-42-treated animals 14 days post-ICV infusion. These findings suggest that hippocampal theta disruption may serve as an early biomarker of network dysfunction in sAD, and that LTG-mediated partial restoration of theta and LTP offers a potential early therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesTheta RhythmPeptide FragmentsLong-Term PotentiationHippocampusTriazinesAlzheimer DiseaseAnimalsLamotrigineMaleRatsBiomarkersDisease Models, Animal

Substanzen

Amyloid beta-PeptidesPeptide Fragmentsamyloid beta-protein (1-42)LamotrigineTriazinesBiomarkers

Autor:innen und Institutionen

  • University of Lodz, Faculty of Biology and Environmental Protection, Department of Oncobiology and Epigenetics, 90-236 Lodz, Poland.
  • Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Transcriptional Regulation, 93-232 Lodz, Poland.
  • Department of Physiology, Maj Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland.
  • Neuroscience Institute, School of Medicine, Stanford University, Palo Alto, CA 94305, USA.
  • University of Lodz, Faculty of Biology and Environmental Protection, Department of Neurobiology, 90-236 Lodz, Poland.
  • Military Institute of Medicine - National Research Institute, 04-141 Warsaw, Poland.

Zitieren

APA

Studzian, M., Bobula, B., MacIver, M. B., Bocian, R., Kobrzycka, A., Caban, B., Kowalczyk, T., Grebowski, J., Michlewska, S., Jankowski, M. M., Tokarski, K., & Kazmierska-Grebowska, P. (2025). Lamotrigine Restores Impairments in Theta Rhythms and LTP as Early Biomarkers of Aβ1-42-Induced Hippocampal Network Dysfunction. aging and disease. https://doi.org/10.14336/ad.2025.0796

Vancouver

Studzian M, Bobula B, MacIver MB, Bocian R, Kobrzycka A, Caban B, et al. Lamotrigine Restores Impairments in Theta Rhythms and LTP as Early Biomarkers of Aβ1-42-Induced Hippocampal Network Dysfunction. aging and disease. 2025. doi:10.14336/ad.2025.0796

BibTeX
@article{Studzian2025,
  author = {Studzian, Maciej and Bobula, Bartosz and MacIver, M Bruce and Bocian, Renata and Kobrzycka, Anna and Caban, Bartosz and Kowalczyk, Tomasz and Grebowski, Jacek and Michlewska, Sylwia and Jankowski, Maciej M and Tokarski, Krzysztof and Kazmierska-Grebowska, Paulina},
  title = {Lamotrigine Restores Impairments in Theta Rhythms and LTP as Early Biomarkers of Aβ1-42-Induced Hippocampal Network Dysfunction},
  journal = {aging and disease},
  year = {2025},
  doi = {10.14336/ad.2025.0796}
}
Kostenlos starten →